Shares Outstanding Shares Outstanding n/a Close	819.52K
Shares Change (YoY) Shares Change (YoY) n/a Close	-44.32%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-42.1%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	6.21%
Shares Floating Shares Floating n/a Close	819.28K
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	38
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.64%

Short Selling Information

The latest short interest is 2.34K, so 0.22% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	2.34K
Short % of Shares Out Short % of Shares Out n/a Close	0.22%
Short % of Float Short % of Float n/a Close	0.28%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1.82

Valuation Ratios

The PE ratio is 1.06 and the forward PE ratio is -1.53. Addex Therapeutics Ltd's PEG ratio is -0.01.

PE Ratio PE Ratio n/a Close	1.06
Forward PE Forward PE n/a Close	-1.53
PS Ratio PS Ratio n/a Close	18.48
Forward PS Forward PS n/a Close	1
PB Ratio PB Ratio n/a Close	0.77
P/FCF Ratio P/FCF Ratio n/a Close	-1.39
PEG Ratio PEG Ratio n/a Close	-0.01

Financial Ratio History

Enterprise Valuation

Addex Therapeutics Ltd has an Enterprise Value (EV) of 892.71M.

EV / Sales EV / Sales n/a Close	2209.13
EV / EBITDA EV / EBITDA n/a Close	-192.16
EV / EBIT EV / EBIT n/a Close	-166.13
EV / FCF EV / FCF n/a Close	-166.09

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.

Current Ratio Current Ratio n/a Close	4.42
Quick Ratio Quick Ratio n/a Close	4.42
Debt / Equity Debt / Equity n/a Close	0
Debt / EBITDA Debt / EBITDA n/a Close	-0.01
Debt / FCF Debt / FCF n/a Close	-0.01
Interest Coverage Interest Coverage n/a Close	-776.78

Financial Efficiency

Return on Equity is 72.91% and Return on Invested Capital is -27.88%.

Return on Equity Return on Equity n/a Close	72.91%
Return on Assets Return on Assets n/a Close	66.08%
Return on Invested Capital Return on Invested Capital n/a Close	-27.88%
Revenue Per Employee Revenue Per Employee n/a Close	$202,051
Profits Per Employee Profits Per Employee n/a Close	$3,527,893.5
Employee Count Employee Count n/a Close	2
Asset Turnover Asset Turnover n/a Close	0.04
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	n/a
Effective Tax Rate Effective Tax Rate n/a Close	0%

Stock Price Statistics

The stock price has increased by -3.95% in the last 52 weeks. The beta is 1.99, so Addex Therapeutics Ltd's price volatility has been higher than the market average.

Beta Beta n/a Close	1.99
52-Week Price Change 52-Week Price Change n/a Close	-3.95%
50-Day Moving Average 50-Day Moving Average n/a Close	7.98
200-Day Moving Average 200-Day Moving Average n/a Close	8.54
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	49.72
Average Volume (20 Days) Average Volume (20 Days) n/a Close	5,923

Income Statement

In the last 12 months, Addex Therapeutics Ltd had revenue of 404.1K and earned 7.06M in profits. Earnings per share was 8.4.

Revenue Revenue n/a Close	404.1K
Gross Profit Gross Profit n/a Close	-444.26K
Operating Income Operating Income n/a Close	-2.76M
Net Income Net Income n/a Close	7.06M
EBITDA EBITDA n/a Close	-4.65M
EBIT EBIT n/a Close	-4.91M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	8.4

Full Income Statement

Balance Sheet

The company has 3.34M in cash and 41.99K in debt, giving a net cash position of 3.3M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	3.34M
Total Debt Total Debt n/a Close	41.99K
Net Cash Net Cash n/a Close	3.3M
Retained Earnings Retained Earnings n/a Close	-353.36M
Total Assets Total Assets n/a Close	12.17M
Working Capital Working Capital n/a Close	3.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.37M and capital expenditures -1.27K, giving a free cash flow of -5.37M.

Operating Cash Flow Operating Cash Flow n/a Close	-5.37M
Capital Expenditures Capital Expenditures n/a Close	-1.27K
Free Cash Flow Free Cash Flow n/a Close	-5.37M
FCF Per Share FCF Per Share n/a Close	-0.04

Full Cash Flow Statement

Margins

Gross margin is -109.94%, with operating and profit margins of -681.82% and 1746.04%.

Gross Margin Gross Margin n/a Close	-109.94%
Operating Margin Operating Margin n/a Close	-681.82%
Pretax Margin Pretax Margin n/a Close	-1214.88%
Profit Margin Profit Margin n/a Close	1746.04%
EBITDA Margin EBITDA Margin n/a Close	-1149.63%
EBIT Margin EBIT Margin n/a Close	-681.82%
FCF Margin FCF Margin n/a Close	-1330.07%

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	94.5%
FCF Yield FCF Yield n/a Close	-0.6%

Dividend Details

Analyst Forecast

The average price target for ADXN is $30, which is 262.8% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$30
Price Target Difference Price Target Difference n/a Close	262.8%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	0.28
Graham Upside Graham Upside n/a Close	-96.61%

Stock Splits

The last stock split was on Oct 23, 2023. It was a backward split with a ratio of 1:20.

Last Split Date Last Split Date n/a Close	Oct 23, 2023
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:20

Scores

Altman Z-Score Altman Z-Score n/a Close	-38.22
Piotroski F-Score Piotroski F-Score n/a Close	4